112 related articles for article (PubMed ID: 9443398)
1. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma.
Nelson PS; Plymate SR; Wang K; True LD; Ware JL; Gan L; Liu AY; Hood L
Cancer Res; 1998 Jan; 58(2):232-6. PubMed ID: 9443398
[TBL] [Abstract][Full Text] [Related]
2. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma.
Lau CP; Poon RT; Cheung ST; Yu WC; Fan ST
J Pathol; 2006 Dec; 210(4):459-68. PubMed ID: 17029219
[TBL] [Abstract][Full Text] [Related]
3. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation.
Claeskens A; Ongenae N; Neefs JM; Cheyns P; Kaijen P; Cools M; Kutoh E
Br J Cancer; 2000 Mar; 82(6):1123-30. PubMed ID: 10735494
[TBL] [Abstract][Full Text] [Related]
4. Neurofilament heavy chain-like messenger RNA and protein are present in benign prostate and down-regulated in prostatic carcinoma.
Schleicher RL; Hunter SB; Zhang M; Zheng M; Tan W; Bandea CI; Fallon MT; Bostwick DG; Varma VA
Cancer Res; 1997 Aug; 57(16):3532-6. PubMed ID: 9270025
[TBL] [Abstract][Full Text] [Related]
5. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
Fujinami K; Uemura H; Ishiguro H; Kubota Y
Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
[TBL] [Abstract][Full Text] [Related]
6. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer.
Bendik I; Schraml P; Ludwig CU
Cancer Res; 1998 Feb; 58(4):626-9. PubMed ID: 9485012
[TBL] [Abstract][Full Text] [Related]
7. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor alpha is an androgen-responsive gene in human prostate and is highly expressed in prostatic adenocarcinoma.
Collett GP; Betts AM; Johnson MI; Pulimood AB; Cook S; Neal DE; Robson CN
Clin Cancer Res; 2000 Aug; 6(8):3241-8. PubMed ID: 10955810
[TBL] [Abstract][Full Text] [Related]
9. Two differentially expressed genes in normal human prostate tissue and in carcinoma.
Wang FL; Wang Y; Wong WK; Liu Y; Addivinola FJ; Liang P; Chen LB; Kantoff PW; Pardee AB
Cancer Res; 1996 Aug; 56(16):3634-7. PubMed ID: 8705997
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
11. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
[TBL] [Abstract][Full Text] [Related]
12. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.
Grzmil M; Voigt S; Thelen P; Hemmerlein B; Helmke K; Burfeind P
Int J Oncol; 2004 Jan; 24(1):97-105. PubMed ID: 14654946
[TBL] [Abstract][Full Text] [Related]
14. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
Tørring N; Jørgensen PE; Sørensen BS; Nexø E
Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639
[TBL] [Abstract][Full Text] [Related]
16. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family.
Sullivan MM; Sage EH
Int J Biochem Cell Biol; 2004 Jun; 36(6):991-6. PubMed ID: 15094114
[TBL] [Abstract][Full Text] [Related]
17. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
[TBL] [Abstract][Full Text] [Related]
19. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
[TBL] [Abstract][Full Text] [Related]
20. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer.
Gnanapragasam VJ; Leung HY; Pulimood AS; Neal DE; Robson CN
Br J Cancer; 2001 Dec; 85(12):1928-36. PubMed ID: 11747336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
